Skip to main content

Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data

PolyCore discloses additional details about its $4.7 million seed round, including participating investors.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.